Oral anticoagulant therapy and outcome in patients with stroke. A retrospective nation‐wide cohort study in Austria 2012–2017

PURPOSE: Patients with stroke are at high risk of recurrence of vascular events. Non‐vitamin K oral anticoagulant (NOAC) and vitamin K antagonists (VKA) are used as secondary prophylaxis. The aim of this study was to evaluate the utilization of NOAC and VKA, and their impact on re‐stroke or death in...

Descripción completa

Detalles Bibliográficos
Autores principales: Preinreich, Jasmina, Sheikh Rezaei, Safoura, Mittlböck, Martina, Greisenegger, Stefan, Reichardt, Berthold, Wolzt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453954/
https://www.ncbi.nlm.nih.gov/pubmed/34021676
http://dx.doi.org/10.1002/pds.5296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453954/
https://www.ncbi.nlm.nih.gov/pubmed/34021676
http://dx.doi.org/10.1002/pds.5296

Ejemplares similares